TD Cowen lifts target for Illumina stock to USD 270.00

Published on 10/15/2026 at 18:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Illumina expects fiscal third-quarter results on October 29, 2026. Illumina stock costs EUR 238.60 on October 15, 2026 at 6:41 p.m. CEST.

Analyst view and dates

On October 13, 2026, TD Cowen lifted its Illumina target to USD 270.00.
Illumina expects fiscal third-quarter results on October 29, 2026.
Illumina stock costs EUR 238.60 at Lang & Schwarz on October 15, 2026 at 6:41 p.m. CEST.
Illumina had a USD 40.4 billion market capitalization and a 49.85 P/E ratio.

CGI-Architekturrender eines modernen Biotech-Hauptgebäudes mit Glasfassade und Wasserbecken — Illumina Inc. Hauptgebäude US4523271090 als fotorealistisches Architektur-Render mit Glasfassade, Spiegelbecken und goldenem Abendlicht, Illustration mit AI erstellt.

TD Cowen raised its price target for Illumina from USD 210.00 to USD 270.00 on October 13, 2026, while retaining a Hold rating, according to Markets Insider. Against the USD 267.50 Nasdaq price on October 15, 2026 at 12:50 p.m. EDT, the new target stood 0.93 percent higher. Illumina stock was trading at EUR 238.60 at Lang & Schwarz on October 15, 2026 at 6:41 p.m. CEST.

October 29 results date

Illumina's next scheduled report is its fiscal third-quarter 2026 earnings release after the market close on October 29, 2026, according to Yahoo Finance. The same report cites expected diluted earnings per share of USD 1.36, compared with USD 1.34 in the year-ago quarter.

USD 93.50 to USD 309.35 range

Illumina's Nasdaq price of USD 267.50 on October 15, 2026 sat 13.54 percent below the USD 309.35 52-week high and well above the USD 93.50 low. Trading volume was 1,302,646 shares against an average of 2,710,220 shares. The current level therefore remains closer to the yearly high than the yearly low.

USD 40.4 billion valuation

Illumina's market capitalization was USD 40.4 billion on October 15, 2026, while its trailing P/E ratio was 49.85. The company reported second-quarter 2026 revenue of USD 1.16 billion, up 9.50 percent from the year-ago quarter, and GAAP diluted earnings per share of USD 1.35, according to Illumina. Fiscal 2026 revenue guidance stood at USD 4.60 billion to USD 4.64 billion, compared with prior guidance of USD 4.52 billion to USD 4.62 billion.

Comparison with peers

Illumina Inc. (Nasdaq, USD): P/E 49.85, market capitalization USD 40.4 billion.
Thermo Fisher Scientific Inc. (NYSE, USD): plus 2.91 percent, P/E 37.24, market capitalization USD 256.1 billion.
Danaher Corporation (NYSE, USD): plus 2.94 percent, P/E 41.11, market capitalization USD 162.6 billion.

Trading perspective

At Lang & Schwarz, Illumina stock was trading at EUR 238.60 on October 15, 2026 at 6:41 p.m. CEST. The Nasdaq price was USD 267.50 on October 15, 2026 at 12:50 p.m. EDT, while the next scheduled company event is the October 29, 2026 earnings release. The further course of trading is shown by the continuously updated real-time quote of Illumina stock.